SlideShare a Scribd company logo
1 of 20
Download to read offline
SEMINAR ON
SYMPATHOMIMETICS DRUGS
INTEGRAL UNIVERSITY, LUCKNOW
M.Pharm Ist Year
2016
PRESENTED BY
Mohd FAHAD
GUIDED BY
MOHD. KHUSHTAR SIR
ADRENERGIC DRUGS
(Sympathomimetics)
These are drugs with actions similar to that of Adr or of
sympathetic stimulation.
Direct sympathomimetics- They act directly as agonists
on α and/or β adrenoceptors –Adr isoprenaline (Iso),
phenylephrine, methoxamine, xylometazoline,
salbutamol and many others.
Indirect sympathomimetics- They act on adrenergic
neurone to release NA, which then acts on the
adrenoceptors- tyramine, amphetamine.
Summary of drug action through modification of adrenergic transmission
Mixed action sympathomimetics- They act directly as
well as indirectly-ephedrine, dopamine, mephentermine.
ACTIONS
The peripheral actions of Adr in most tissues have been
clearly differentiated into those mediated by α or β
receptors depending on the predominant receptor type
present in a given tissue.
The receptor subtype, wherever defined, has been
mentioned in parenthesis. The actions of a particular
sympathomimetic amine depend on its relative activity at
different types of adrenergic receptors.
Adrenergic responses mediated through α and β receptors
The overall actions are -
1. Heart- Adr increases heart rate by increasing the slope of slow
diastolic depolarization of cells in the SA node. It also activates latent
pacemakers in A-V node.
Arrhythmias can occur with high doses that raise BP
markedly. Raised BP reflexly depresses the SA node and unmasks the
latent pacemakers. Certain anaesthetics (chloroform, haloethane)
sensitize the heart to arrhythmic action of Adr. Idioventricular rate is
increased in patients with complete heart block.
2. Blood vessels- Both vasoconstriction (α) and vasodilatation
(β2) can occur depending on the drug, its dose and vascular bed.
Constriction predominates in cutaneous, mucous membrane and renal
beds. Vasoconstriction occurs through both α1 and α2 receptors.
3. BP- The effect depends on the amine, its dose and rate of
administration.
• NA causes rise in systolic, diastolic and mean BP; it does not cause
vasodilatation (no β2 action), peripheral resistance increases
consistently due to α action.
4. Respiration- Adr and isoprenaline, but not NA are potent
bronchodilators (β2). This action is more marked when the bronchi
are constricted.
5. Eye- Mydriasis occurs due to contraction of radial muscles of
iris (a1), but this is minimal after topical application, because Adr
penetrates cornea poorly. The intraocular tension tends to fall,
especially in wide angle glaucoma.
6. GIT In isolated preparations of gut, relaxation occurs through
activation of both α and β receptors. in intact animals and man
peristalsis is reduced and sphincters are constricted.
7. Bladder Detrusor is relaxed (β) and trigone is constricted (α):
both actions tend to hinder micturition.
8. Uterus Adr can both contract and relax uterine muscle,
respectively through α and β receptors. The overall effect varies with
species, hormonal and gestational status.
9. Skeletal muscle Neuromuscular transmission is facilitated .
In contrast to action on autonomic nerve endings, a receptor activation
on motor nerve endings augments ACh release, probably because it is
of the α1 subtype.
10.CNS Adr, in clinically used doses, does not produce any
marked CNS effects because of poor penetration in brain, but
restlessness, apprehension and tremor may occur. Activation of α2
receptors in the brainstem results in decreased sympathetic outflow
→ fall in BP and bradycardia.
11.Metabolic Adr produces glycogenolysis→hyperglycaemia,
hyperlactacidaemia (β2); lypolysis→rise in plasma free fatty acid
(FFA), calorigenesis (β2 + β3) and transient hyperkalaemia followed
by hypokalaemia due to direct action on liver, muscle and adipose
tissue cells. In addition metabolic effects result from reduction of
insulin (α2) and augmentation of glucagon (β2)secretion.
Administration and preparations
CAs are absorbed from the intestine but are rapidly degraded by
MAO and COMT present in the intestinal wall and liver. They are
thus orally inactive.
1. Adrenaline (Epinephrine) For systemic action, 0.2-0.5 mg s.c.,
i.m., action lasts 0.5 to 2 hrs.
ADRENALINE 1 mg/ml inj.
2. Noradrenaline (Norepinephrine, levarterenol) 2-4 μg/min i.v.
infusion; local tissue necrosis occurs if the solution extravasates; do
not mix with NaHC03in the same bottle (rapid oxidation occurs);
action starts declining within 5 min of discontinuing infusion. It is
rarely used now as a pressor agent. ADRENOR, NORAD, VASCUE,
NORDRIN 2 mg (base)/2 ml amp.
3. Isoprenaline (Isoproterenol) 20 mg sublingual, 1-2 mg i.m., 5-10
μg/min i.v. infusion; action lasts 1-3 hrs. It is occasionally used to
maintain idioventricular rate till pacemaker is implanted. For
bronchial asthma, it has been superseded by selective β2 agonists.
ISOPRIN 4 mg/2 ml inj, NEOEPlNINE 20 mg sublingual tablets.
Adverse effects and contraindications
• Transient restlessness, palpitation, anxiety, tremor, pallor may
occur after s.c. /i.m. injection of Adr.
• Marked rise in BP leading to cerebral haemorrhage, ventricular
tachycardia/ fibrillation,
angina, myocardial infarction are the hazards of large doses or
inadvertant i.v. injection of Adr.
• Adr is contraindicated in hypertensive, hyperthyroid and angina
patients.
• Adr should not be given during anaesthesia with halothane (risk of
arrhythmias) and to patients receiving β blockers (marked rise in BP
can occur due to unopposed α action).
THERAPEUTIC CLASSIFICATION OF
ADRENERGIC DRUGS
1. Pressor agents
Noradrenaline Phenylephrine
Ephedrine Methoxamine
Dopamine Mephentermine
2. Cardiac stimulants
Adrenaline Isoprenaline
3. Bronchodilators
Isoprenaline salmeterol
Salbutamol formoterol
Terbutaline Dobutamine
4. Nasal decongestants
Phenylephrine Naphazoline
Xylometazoline Pseudoephedrine
Oxymetazoline Phenyl propanolamine
5. CNS stimulants
Amphetamine Methamphetamine
Dexamphetamine
6. Anorectics
Fenfluramine Sibutramine
Dexfenfluramine
7. Uterine relaxant and vasodilators
Ritodrine Salbutamol
Isoxsuprine Terbutaline
Salient features of important adrenergic drugs are
described below
Dopamine (DA) Dopamine is used in patients of cardiogenic or
septic shock and severe CHF wherein it increases BP and urine
outflow. It is administered by i.v. infusion (0.2-1 mg/min) which
is regulated by monitoring BP and rate of urine formation.
DOPAMINE, INTROPIN, DOPACARD 200 mg in 5 ml amp.
DOBUTAMINE It is used as an inotropic agent in pump failure
accompanying myocardial infarction, cardiac surgery, and for
short term management of severe congestive heart failure. It is
less arrhythmogenic than Adr.
CRDIJECT 50 mg/4 ml and 250 mg per 20 ml amp,
DOBUTREX, DOBUSTAT 250 mg vial.
Ephedrine Ephedrine can be used for a variety of purposes, but
it lacks selectivity, and efficacy is low. Use is now restricted to
that in mild chronic bronchial asthma and for hypotension during
spinal anaesthesia; occasionally for postural hypotension; 15-60
mg TDS.
EPHEDRINE HCL 15, 30 mg tab; SULFIDRIN 50 mg in 1 ml
inj, in ENDRINE 0.75% nasal drops.
Amphetamines Amphetamines stimulate respiratory centre,
specially if it has been depressed. Hunger is suppressed as a result
of inhibition of hypothalamic feeding centre. They also have weak
anticonvulsant, analgesic and antiemetic actions: potentiate
antiepileptics, analgesics and antimotion-sickness drugs.
Amphetamines are drugs of abuse and are capable of
producing marked psychological but little or no physical
dependence.
Amphetamine abusers are generally teenagers seeking thrill or
kick which is obtained on rapid i.v. injection. High doses produce
euphoria, marked excitement which may progress to mental
confusion, delirium, hallucinations and an acute psychotic state.
Treatment of amphetamine toxicity includes administration of
chlorpromazine which controls both central as well as peripheral a
adrenergic effects. The central actions are largely mediated by
release of NA in the brain. However, certain actions are probably
due to DA and 5-HT release.
It also inhibits neuronal uptake of DA.
Amphetamine: 5-15 mg oral; BENZEDRINE 5 mg tab.
Dexamphetamine: 5-10 mg (children 2.5-5 mg) oral.
Phenylephrine Phenylephrine tends to reduce intraocular
tension by constricting ciliary body blood vessels. it is also a
frequent constituent of orally administrated nasal decongestant
preparations. Central effects are not seen with usual clinical
doses.
Dose 2-5 mg i.m., 0.1-0.5 mg slow i.v. inj, 30-60 μg/min
i.v. infusion; 5-10 mg oral; 0.25-5% nasal instillation;
5-10% topically in eye;
FRENIN 10 mg in 1 ml inj; DECOLD PLUS 5 mg with
paracetamol 400 mg + chlorpheniramine 2 mg + caffeine 15mg
tab.
Methoxamine Methoxamine Another selective α1 agonist with
no β actions (has weak β blocking action). Resembles
phenylephrine very closely. Occasionally used as a pressor agent.
Dose: 10-20 mg i.m.; 3-5 mg slow i.v. inj.
VASOXINE 20 mg/ml inj.
THERAPEUTIC USES
1. Vascular Uses
(i) Hypotensive states (shock, spinal anaesthesia, hypotensive drugs)
One of the pressor agents can be used along with volume
replacement for neurogenic and haemorrhagic shock; also as an
expedient measure to maintain cerebral circulation for other varieties
of shock. They should not be used in secondary shock when reflex
vasoconstriction is already marked. Use in cardiogenic shock is
tricky, because attempts to raise BP may also increase cardiac work.
Slow i.v. infusion of dopamine/dobutamine is more appropriate in
this situation; use of NA is practically obsolete. Adr 0.5 mg injected
promptly i.m. is the drug of choice in anaphylactic shock. It not only
raises BP, but counteracts bronchospasm/ laryngeal edema that may
accompany.
Because of the rapidity an profile of action Adr is the only life
saving measure. Oral ephedrine has been used to treat postural
hypotension due to autonomic neuropathy (diabetes, parkinsonism,
idiopathic) or advanced age. However, it is not satisfactory because
it cannot mimic selective NA release that occurs only on standing.
Elastic stockings and use of fludrocortisone to expand plasma
volume are more helpful.

More Related Content

Similar to sympathomimetics-180115093558.pdf

Final presentation -pharmacology
Final presentation  -pharmacologyFinal presentation  -pharmacology
Final presentation -pharmacologyamrit pandey
 
Antiemetic Drugs
Antiemetic DrugsAntiemetic Drugs
Antiemetic DrugsMrunalAkre
 
Sympatholytics by kahkesha
Sympatholytics   by kahkeshaSympatholytics   by kahkesha
Sympatholytics by kahkeshakahkesha samshad
 
DRUGS ACTING ON AUTONOMIC NERVOUS SYSTEM 2nd Semester.pptx
DRUGS ACTING ON AUTONOMIC NERVOUS SYSTEM 2nd Semester.pptxDRUGS ACTING ON AUTONOMIC NERVOUS SYSTEM 2nd Semester.pptx
DRUGS ACTING ON AUTONOMIC NERVOUS SYSTEM 2nd Semester.pptxSaithanpari
 
Malik sedation
Malik sedationMalik sedation
Malik sedationEM OMSB
 
Anxiolytics by Mwebaza victor MBchB.pdf
Anxiolytics by Mwebaza victor MBchB.pdfAnxiolytics by Mwebaza victor MBchB.pdf
Anxiolytics by Mwebaza victor MBchB.pdfDr. MWEBAZA VICTOR
 
Adrenergic drugs and there classification
Adrenergic drugs and there  classificationAdrenergic drugs and there  classification
Adrenergic drugs and there classificationNitin Vaidya
 
Local aneshesia administration protocol
Local aneshesia administration protocolLocal aneshesia administration protocol
Local aneshesia administration protocolworkneh tesfaye
 
1.salbutamol sulfate (Ventolin)- the molecular formula of salbutamo.pdf
1.salbutamol sulfate (Ventolin)- the molecular formula of salbutamo.pdf1.salbutamol sulfate (Ventolin)- the molecular formula of salbutamo.pdf
1.salbutamol sulfate (Ventolin)- the molecular formula of salbutamo.pdfaquacare2008
 
Sympathomimetic drugs
Sympathomimetic drugsSympathomimetic drugs
Sympathomimetic drugsDrSEERATIQBAL
 
Systemic Pharmacology Of Autonomic Nervous System. Sympathomimetics Agents
Systemic Pharmacology Of Autonomic Nervous System. Sympathomimetics AgentsSystemic Pharmacology Of Autonomic Nervous System. Sympathomimetics Agents
Systemic Pharmacology Of Autonomic Nervous System. Sympathomimetics AgentsAshish Gadage
 
Sympathomimetics Drugs. Pharmacology WA0004..pptx
Sympathomimetics Drugs. Pharmacology WA0004..pptxSympathomimetics Drugs. Pharmacology WA0004..pptx
Sympathomimetics Drugs. Pharmacology WA0004..pptxIntegral University
 
Adrenergic Agonists and antagonists.pdf
Adrenergic Agonists and antagonists.pdfAdrenergic Agonists and antagonists.pdf
Adrenergic Agonists and antagonists.pdfSaishDalvi
 
Adrenergic drugs
Adrenergic drugsAdrenergic drugs
Adrenergic drugsSahil Patil
 
Sympathomimetic agents/ Adrenergic drug
Sympathomimetic agents/ Adrenergic drugSympathomimetic agents/ Adrenergic drug
Sympathomimetic agents/ Adrenergic drugSKarthigaSVCP
 
Anti parkinsonian drugs
Anti parkinsonian drugsAnti parkinsonian drugs
Anti parkinsonian drugsSharique Ayaz
 

Similar to sympathomimetics-180115093558.pdf (20)

Final presentation -pharmacology
Final presentation  -pharmacologyFinal presentation  -pharmacology
Final presentation -pharmacology
 
Antiemetic Drugs
Antiemetic DrugsAntiemetic Drugs
Antiemetic Drugs
 
Sympatholytics by kahkesha
Sympatholytics   by kahkeshaSympatholytics   by kahkesha
Sympatholytics by kahkesha
 
Anti epileptic drugs
Anti epileptic drugsAnti epileptic drugs
Anti epileptic drugs
 
pediaric PSA
pediaric PSApediaric PSA
pediaric PSA
 
DRUGS ACTING ON AUTONOMIC NERVOUS SYSTEM 2nd Semester.pptx
DRUGS ACTING ON AUTONOMIC NERVOUS SYSTEM 2nd Semester.pptxDRUGS ACTING ON AUTONOMIC NERVOUS SYSTEM 2nd Semester.pptx
DRUGS ACTING ON AUTONOMIC NERVOUS SYSTEM 2nd Semester.pptx
 
Malik sedation
Malik sedationMalik sedation
Malik sedation
 
Anxiolytics by Mwebaza victor MBchB.pdf
Anxiolytics by Mwebaza victor MBchB.pdfAnxiolytics by Mwebaza victor MBchB.pdf
Anxiolytics by Mwebaza victor MBchB.pdf
 
Adrenergic drugs and there classification
Adrenergic drugs and there  classificationAdrenergic drugs and there  classification
Adrenergic drugs and there classification
 
Local aneshesia administration protocol
Local aneshesia administration protocolLocal aneshesia administration protocol
Local aneshesia administration protocol
 
1.salbutamol sulfate (Ventolin)- the molecular formula of salbutamo.pdf
1.salbutamol sulfate (Ventolin)- the molecular formula of salbutamo.pdf1.salbutamol sulfate (Ventolin)- the molecular formula of salbutamo.pdf
1.salbutamol sulfate (Ventolin)- the molecular formula of salbutamo.pdf
 
Sympathomimetic drugs
Sympathomimetic drugsSympathomimetic drugs
Sympathomimetic drugs
 
Systemic Pharmacology Of Autonomic Nervous System. Sympathomimetics Agents
Systemic Pharmacology Of Autonomic Nervous System. Sympathomimetics AgentsSystemic Pharmacology Of Autonomic Nervous System. Sympathomimetics Agents
Systemic Pharmacology Of Autonomic Nervous System. Sympathomimetics Agents
 
MFD New Meds
MFD New MedsMFD New Meds
MFD New Meds
 
Sympathomimetics Drugs. Pharmacology WA0004..pptx
Sympathomimetics Drugs. Pharmacology WA0004..pptxSympathomimetics Drugs. Pharmacology WA0004..pptx
Sympathomimetics Drugs. Pharmacology WA0004..pptx
 
Adrenergic Agonists and antagonists.pdf
Adrenergic Agonists and antagonists.pdfAdrenergic Agonists and antagonists.pdf
Adrenergic Agonists and antagonists.pdf
 
Adrenergic drugs
Adrenergic drugsAdrenergic drugs
Adrenergic drugs
 
Atropine
Atropine Atropine
Atropine
 
Sympathomimetic agents/ Adrenergic drug
Sympathomimetic agents/ Adrenergic drugSympathomimetic agents/ Adrenergic drug
Sympathomimetic agents/ Adrenergic drug
 
Anti parkinsonian drugs
Anti parkinsonian drugsAnti parkinsonian drugs
Anti parkinsonian drugs
 

More from ChintuCH1

rheologydone-160221102012.pdf
rheologydone-160221102012.pdfrheologydone-160221102012.pdf
rheologydone-160221102012.pdfChintuCH1
 
antidepressants-210723100900.pdf
antidepressants-210723100900.pdfantidepressants-210723100900.pdf
antidepressants-210723100900.pdfChintuCH1
 
morphine-171119024007.pdf
morphine-171119024007.pdfmorphine-171119024007.pdf
morphine-171119024007.pdfChintuCH1
 
morphinefentanylnida-151117150328-lva1-app6891.pdf
morphinefentanylnida-151117150328-lva1-app6891.pdfmorphinefentanylnida-151117150328-lva1-app6891.pdf
morphinefentanylnida-151117150328-lva1-app6891.pdfChintuCH1
 
opioidanalgesics-111029153320-phpapp01.pdf
opioidanalgesics-111029153320-phpapp01.pdfopioidanalgesics-111029153320-phpapp01.pdf
opioidanalgesics-111029153320-phpapp01.pdfChintuCH1
 
carbamazepinepublic-121124195050-phpapp01.pdf
carbamazepinepublic-121124195050-phpapp01.pdfcarbamazepinepublic-121124195050-phpapp01.pdf
carbamazepinepublic-121124195050-phpapp01.pdfChintuCH1
 
preanaestheticmedicationgeneralanaesthetics-140927081752-phpapp01.pdf
preanaestheticmedicationgeneralanaesthetics-140927081752-phpapp01.pdfpreanaestheticmedicationgeneralanaesthetics-140927081752-phpapp01.pdf
preanaestheticmedicationgeneralanaesthetics-140927081752-phpapp01.pdfChintuCH1
 
adrenalinenoradrenaline-150926040208-lva1-app6892.pdf
adrenalinenoradrenaline-150926040208-lva1-app6892.pdfadrenalinenoradrenaline-150926040208-lva1-app6892.pdf
adrenalinenoradrenaline-150926040208-lva1-app6892.pdfChintuCH1
 
adrenalin-180418180059.pdf
adrenalin-180418180059.pdfadrenalin-180418180059.pdf
adrenalin-180418180059.pdfChintuCH1
 
adrenalinefinalised-200703102926.pdf
adrenalinefinalised-200703102926.pdfadrenalinefinalised-200703102926.pdf
adrenalinefinalised-200703102926.pdfChintuCH1
 
pyrrole-200404172118 (1).pdf
pyrrole-200404172118 (1).pdfpyrrole-200404172118 (1).pdf
pyrrole-200404172118 (1).pdfChintuCH1
 
Colloidal dispersion
Colloidal dispersion Colloidal dispersion
Colloidal dispersion ChintuCH1
 

More from ChintuCH1 (12)

rheologydone-160221102012.pdf
rheologydone-160221102012.pdfrheologydone-160221102012.pdf
rheologydone-160221102012.pdf
 
antidepressants-210723100900.pdf
antidepressants-210723100900.pdfantidepressants-210723100900.pdf
antidepressants-210723100900.pdf
 
morphine-171119024007.pdf
morphine-171119024007.pdfmorphine-171119024007.pdf
morphine-171119024007.pdf
 
morphinefentanylnida-151117150328-lva1-app6891.pdf
morphinefentanylnida-151117150328-lva1-app6891.pdfmorphinefentanylnida-151117150328-lva1-app6891.pdf
morphinefentanylnida-151117150328-lva1-app6891.pdf
 
opioidanalgesics-111029153320-phpapp01.pdf
opioidanalgesics-111029153320-phpapp01.pdfopioidanalgesics-111029153320-phpapp01.pdf
opioidanalgesics-111029153320-phpapp01.pdf
 
carbamazepinepublic-121124195050-phpapp01.pdf
carbamazepinepublic-121124195050-phpapp01.pdfcarbamazepinepublic-121124195050-phpapp01.pdf
carbamazepinepublic-121124195050-phpapp01.pdf
 
preanaestheticmedicationgeneralanaesthetics-140927081752-phpapp01.pdf
preanaestheticmedicationgeneralanaesthetics-140927081752-phpapp01.pdfpreanaestheticmedicationgeneralanaesthetics-140927081752-phpapp01.pdf
preanaestheticmedicationgeneralanaesthetics-140927081752-phpapp01.pdf
 
adrenalinenoradrenaline-150926040208-lva1-app6892.pdf
adrenalinenoradrenaline-150926040208-lva1-app6892.pdfadrenalinenoradrenaline-150926040208-lva1-app6892.pdf
adrenalinenoradrenaline-150926040208-lva1-app6892.pdf
 
adrenalin-180418180059.pdf
adrenalin-180418180059.pdfadrenalin-180418180059.pdf
adrenalin-180418180059.pdf
 
adrenalinefinalised-200703102926.pdf
adrenalinefinalised-200703102926.pdfadrenalinefinalised-200703102926.pdf
adrenalinefinalised-200703102926.pdf
 
pyrrole-200404172118 (1).pdf
pyrrole-200404172118 (1).pdfpyrrole-200404172118 (1).pdf
pyrrole-200404172118 (1).pdf
 
Colloidal dispersion
Colloidal dispersion Colloidal dispersion
Colloidal dispersion
 

Recently uploaded

mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docxPoojaSen20
 
Crayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon ACrayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon AUnboundStockton
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...Marc Dusseiller Dusjagr
 
Concept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.CompdfConcept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.CompdfUmakantAnnand
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxGaneshChakor2
 
URLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppURLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppCeline George
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentInMediaRes1
 
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxContemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxRoyAbrique
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3JemimahLaneBuaron
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionSafetyChain Software
 
Separation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesSeparation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesFatimaKhan178732
 
PSYCHIATRIC History collection FORMAT.pptx
PSYCHIATRIC   History collection FORMAT.pptxPSYCHIATRIC   History collection FORMAT.pptx
PSYCHIATRIC History collection FORMAT.pptxPoojaSen20
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)eniolaolutunde
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdfSoniaTolstoy
 
Science 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsScience 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsKarinaGenton
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxheathfieldcps1
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxSayali Powar
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfsanyamsingh5019
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptxVS Mahajan Coaching Centre
 

Recently uploaded (20)

mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docx
 
Crayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon ACrayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon A
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
 
Concept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.CompdfConcept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.Compdf
 
Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptx
 
URLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppURLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website App
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media Component
 
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxContemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory Inspection
 
Separation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesSeparation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and Actinides
 
PSYCHIATRIC History collection FORMAT.pptx
PSYCHIATRIC   History collection FORMAT.pptxPSYCHIATRIC   History collection FORMAT.pptx
PSYCHIATRIC History collection FORMAT.pptx
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
 
Science 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsScience 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its Characteristics
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdf
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
 

sympathomimetics-180115093558.pdf

  • 1. SEMINAR ON SYMPATHOMIMETICS DRUGS INTEGRAL UNIVERSITY, LUCKNOW M.Pharm Ist Year 2016 PRESENTED BY Mohd FAHAD GUIDED BY MOHD. KHUSHTAR SIR
  • 2. ADRENERGIC DRUGS (Sympathomimetics) These are drugs with actions similar to that of Adr or of sympathetic stimulation. Direct sympathomimetics- They act directly as agonists on α and/or β adrenoceptors –Adr isoprenaline (Iso), phenylephrine, methoxamine, xylometazoline, salbutamol and many others. Indirect sympathomimetics- They act on adrenergic neurone to release NA, which then acts on the adrenoceptors- tyramine, amphetamine.
  • 3. Summary of drug action through modification of adrenergic transmission
  • 4. Mixed action sympathomimetics- They act directly as well as indirectly-ephedrine, dopamine, mephentermine. ACTIONS The peripheral actions of Adr in most tissues have been clearly differentiated into those mediated by α or β receptors depending on the predominant receptor type present in a given tissue. The receptor subtype, wherever defined, has been mentioned in parenthesis. The actions of a particular sympathomimetic amine depend on its relative activity at different types of adrenergic receptors.
  • 5. Adrenergic responses mediated through α and β receptors
  • 6. The overall actions are - 1. Heart- Adr increases heart rate by increasing the slope of slow diastolic depolarization of cells in the SA node. It also activates latent pacemakers in A-V node. Arrhythmias can occur with high doses that raise BP markedly. Raised BP reflexly depresses the SA node and unmasks the latent pacemakers. Certain anaesthetics (chloroform, haloethane) sensitize the heart to arrhythmic action of Adr. Idioventricular rate is increased in patients with complete heart block. 2. Blood vessels- Both vasoconstriction (α) and vasodilatation (β2) can occur depending on the drug, its dose and vascular bed. Constriction predominates in cutaneous, mucous membrane and renal beds. Vasoconstriction occurs through both α1 and α2 receptors.
  • 7. 3. BP- The effect depends on the amine, its dose and rate of administration. • NA causes rise in systolic, diastolic and mean BP; it does not cause vasodilatation (no β2 action), peripheral resistance increases consistently due to α action. 4. Respiration- Adr and isoprenaline, but not NA are potent bronchodilators (β2). This action is more marked when the bronchi are constricted. 5. Eye- Mydriasis occurs due to contraction of radial muscles of iris (a1), but this is minimal after topical application, because Adr penetrates cornea poorly. The intraocular tension tends to fall, especially in wide angle glaucoma.
  • 8. 6. GIT In isolated preparations of gut, relaxation occurs through activation of both α and β receptors. in intact animals and man peristalsis is reduced and sphincters are constricted. 7. Bladder Detrusor is relaxed (β) and trigone is constricted (α): both actions tend to hinder micturition. 8. Uterus Adr can both contract and relax uterine muscle, respectively through α and β receptors. The overall effect varies with species, hormonal and gestational status. 9. Skeletal muscle Neuromuscular transmission is facilitated . In contrast to action on autonomic nerve endings, a receptor activation on motor nerve endings augments ACh release, probably because it is of the α1 subtype.
  • 9. 10.CNS Adr, in clinically used doses, does not produce any marked CNS effects because of poor penetration in brain, but restlessness, apprehension and tremor may occur. Activation of α2 receptors in the brainstem results in decreased sympathetic outflow → fall in BP and bradycardia. 11.Metabolic Adr produces glycogenolysis→hyperglycaemia, hyperlactacidaemia (β2); lypolysis→rise in plasma free fatty acid (FFA), calorigenesis (β2 + β3) and transient hyperkalaemia followed by hypokalaemia due to direct action on liver, muscle and adipose tissue cells. In addition metabolic effects result from reduction of insulin (α2) and augmentation of glucagon (β2)secretion.
  • 10. Administration and preparations CAs are absorbed from the intestine but are rapidly degraded by MAO and COMT present in the intestinal wall and liver. They are thus orally inactive. 1. Adrenaline (Epinephrine) For systemic action, 0.2-0.5 mg s.c., i.m., action lasts 0.5 to 2 hrs. ADRENALINE 1 mg/ml inj. 2. Noradrenaline (Norepinephrine, levarterenol) 2-4 μg/min i.v. infusion; local tissue necrosis occurs if the solution extravasates; do not mix with NaHC03in the same bottle (rapid oxidation occurs); action starts declining within 5 min of discontinuing infusion. It is rarely used now as a pressor agent. ADRENOR, NORAD, VASCUE, NORDRIN 2 mg (base)/2 ml amp.
  • 11. 3. Isoprenaline (Isoproterenol) 20 mg sublingual, 1-2 mg i.m., 5-10 μg/min i.v. infusion; action lasts 1-3 hrs. It is occasionally used to maintain idioventricular rate till pacemaker is implanted. For bronchial asthma, it has been superseded by selective β2 agonists. ISOPRIN 4 mg/2 ml inj, NEOEPlNINE 20 mg sublingual tablets.
  • 12. Adverse effects and contraindications • Transient restlessness, palpitation, anxiety, tremor, pallor may occur after s.c. /i.m. injection of Adr. • Marked rise in BP leading to cerebral haemorrhage, ventricular tachycardia/ fibrillation, angina, myocardial infarction are the hazards of large doses or inadvertant i.v. injection of Adr. • Adr is contraindicated in hypertensive, hyperthyroid and angina patients. • Adr should not be given during anaesthesia with halothane (risk of arrhythmias) and to patients receiving β blockers (marked rise in BP can occur due to unopposed α action).
  • 13. THERAPEUTIC CLASSIFICATION OF ADRENERGIC DRUGS 1. Pressor agents Noradrenaline Phenylephrine Ephedrine Methoxamine Dopamine Mephentermine 2. Cardiac stimulants Adrenaline Isoprenaline 3. Bronchodilators Isoprenaline salmeterol Salbutamol formoterol Terbutaline Dobutamine 4. Nasal decongestants Phenylephrine Naphazoline Xylometazoline Pseudoephedrine Oxymetazoline Phenyl propanolamine
  • 14. 5. CNS stimulants Amphetamine Methamphetamine Dexamphetamine 6. Anorectics Fenfluramine Sibutramine Dexfenfluramine 7. Uterine relaxant and vasodilators Ritodrine Salbutamol Isoxsuprine Terbutaline
  • 15. Salient features of important adrenergic drugs are described below Dopamine (DA) Dopamine is used in patients of cardiogenic or septic shock and severe CHF wherein it increases BP and urine outflow. It is administered by i.v. infusion (0.2-1 mg/min) which is regulated by monitoring BP and rate of urine formation. DOPAMINE, INTROPIN, DOPACARD 200 mg in 5 ml amp. DOBUTAMINE It is used as an inotropic agent in pump failure accompanying myocardial infarction, cardiac surgery, and for short term management of severe congestive heart failure. It is less arrhythmogenic than Adr. CRDIJECT 50 mg/4 ml and 250 mg per 20 ml amp, DOBUTREX, DOBUSTAT 250 mg vial.
  • 16. Ephedrine Ephedrine can be used for a variety of purposes, but it lacks selectivity, and efficacy is low. Use is now restricted to that in mild chronic bronchial asthma and for hypotension during spinal anaesthesia; occasionally for postural hypotension; 15-60 mg TDS. EPHEDRINE HCL 15, 30 mg tab; SULFIDRIN 50 mg in 1 ml inj, in ENDRINE 0.75% nasal drops. Amphetamines Amphetamines stimulate respiratory centre, specially if it has been depressed. Hunger is suppressed as a result of inhibition of hypothalamic feeding centre. They also have weak anticonvulsant, analgesic and antiemetic actions: potentiate antiepileptics, analgesics and antimotion-sickness drugs. Amphetamines are drugs of abuse and are capable of producing marked psychological but little or no physical dependence.
  • 17. Amphetamine abusers are generally teenagers seeking thrill or kick which is obtained on rapid i.v. injection. High doses produce euphoria, marked excitement which may progress to mental confusion, delirium, hallucinations and an acute psychotic state. Treatment of amphetamine toxicity includes administration of chlorpromazine which controls both central as well as peripheral a adrenergic effects. The central actions are largely mediated by release of NA in the brain. However, certain actions are probably due to DA and 5-HT release. It also inhibits neuronal uptake of DA. Amphetamine: 5-15 mg oral; BENZEDRINE 5 mg tab. Dexamphetamine: 5-10 mg (children 2.5-5 mg) oral.
  • 18. Phenylephrine Phenylephrine tends to reduce intraocular tension by constricting ciliary body blood vessels. it is also a frequent constituent of orally administrated nasal decongestant preparations. Central effects are not seen with usual clinical doses. Dose 2-5 mg i.m., 0.1-0.5 mg slow i.v. inj, 30-60 μg/min i.v. infusion; 5-10 mg oral; 0.25-5% nasal instillation; 5-10% topically in eye; FRENIN 10 mg in 1 ml inj; DECOLD PLUS 5 mg with paracetamol 400 mg + chlorpheniramine 2 mg + caffeine 15mg tab. Methoxamine Methoxamine Another selective α1 agonist with no β actions (has weak β blocking action). Resembles phenylephrine very closely. Occasionally used as a pressor agent. Dose: 10-20 mg i.m.; 3-5 mg slow i.v. inj. VASOXINE 20 mg/ml inj.
  • 19. THERAPEUTIC USES 1. Vascular Uses (i) Hypotensive states (shock, spinal anaesthesia, hypotensive drugs) One of the pressor agents can be used along with volume replacement for neurogenic and haemorrhagic shock; also as an expedient measure to maintain cerebral circulation for other varieties of shock. They should not be used in secondary shock when reflex vasoconstriction is already marked. Use in cardiogenic shock is tricky, because attempts to raise BP may also increase cardiac work. Slow i.v. infusion of dopamine/dobutamine is more appropriate in this situation; use of NA is practically obsolete. Adr 0.5 mg injected promptly i.m. is the drug of choice in anaphylactic shock. It not only raises BP, but counteracts bronchospasm/ laryngeal edema that may accompany.
  • 20. Because of the rapidity an profile of action Adr is the only life saving measure. Oral ephedrine has been used to treat postural hypotension due to autonomic neuropathy (diabetes, parkinsonism, idiopathic) or advanced age. However, it is not satisfactory because it cannot mimic selective NA release that occurs only on standing. Elastic stockings and use of fludrocortisone to expand plasma volume are more helpful.